Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call on...